4.6 Review

Type 2 diabetes: new genes, new understanding

Journal

TRENDS IN GENETICS
Volume 24, Issue 12, Pages 613-621

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tig.2008.09.004

Keywords

-

Funding

  1. European Commission [HEALTH-F4-2007-201413]
  2. Medical Research Council [G0601261]
  3. Oxford NIHR Biomedical Research Centre
  4. Diabetes UK
  5. Wellcome Trust
  6. MRC [G0601261] Funding Source: UKRI
  7. Medical Research Council [G0601261] Funding Source: researchfish

Ask authors/readers for more resources

Over the past two years, there has been a spectacular change in the capacity to identify common genetic variants that contribute to predisposition to complex multifactorial phenotypes such as type 2 diabetes (T2D). The principal advance has been the ability to undertake surveys of genome-wide association in large study samples. Through these and related efforts, similar to 20 common variants are now robustly implicated in T2D susceptibility. Current developments, for example in high-throughput resequencing, should help to provide a more comprehensive view of T2D susceptibility in the near future. Although additional investigation is needed to define the causal variants within these novel T2D-susceptibility regions, to understand disease mechanisms and to effect clinical translation, these findings are already highlighting the predominant contribution of defects in pancreatic beta-cell function to the development of T21D.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available